Group K Diagnostics Relocates to New Laboratory, Manufacturing and Office Space in Philadelphia

Previous PostENB Therapeutics Announces Clinical Trial Collaboration with Merck to Evaluate ENB-003 in combination with KEYTRUDA(R) (pembrolizumab) for Advanced Solid Tumors